DZ2954A1 - Antagoniste des recepteurs de vitronectine, procédé pour sa préparation et compositions pharmaceutiques le contenant. - Google Patents

Antagoniste des recepteurs de vitronectine, procédé pour sa préparation et compositions pharmaceutiques le contenant.

Info

Publication number: DZ2954A1
Authority: DZ; Algeria
Prior art keywords: preparation; pharmaceutical compositions; compositions containing; receptor antagonist; vitronectin receptor
Prior art date: 1998-12-04

Application number

DZ990254A

Other languages

English (en)

Inventor

William H Miller

Peter J Manley

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-12-04

Filing date

1999-12-01

Publication date

2004-06-20

1999-12-01 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

2004-06-20 Application granted granted Critical

2004-06-20 Publication of DZ2954A1 publication Critical patent/DZ2954A1/fr

Links

102100022337 Integrin alpha-V Human genes 0.000 title 1
108010048673 Vitronectin Receptors Proteins 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
239000002464 receptor antagonist Substances 0.000 title 1
229940044551 receptor antagonist Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pulmonology (AREA)
Cardiology (AREA)
Inorganic Chemistry (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Transplantation (AREA)
Vascular Medicine (AREA)
Hematology (AREA)
Dermatology (AREA)
Diabetes (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Peptides Or Proteins (AREA)

DZ990254A 1998-12-04 1999-12-01 Antagoniste des recepteurs de vitronectine, procédé pour sa préparation et compositions pharmaceutiques le contenant. DZ2954A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US11090398P	1998-12-04	1998-12-04

Publications (1)

Publication Number	Publication Date
DZ2954A1 true DZ2954A1 (fr)	2004-06-20

Family

ID=22335565

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ990254A DZ2954A1 (fr)	1998-12-04	1999-12-01	Antagoniste des recepteurs de vitronectine, procédé pour sa préparation et compositions pharmaceutiques le contenant.

Country Status (39)

Country	Link
US (1)	US6495560B1 (fr)
EP (1)	EP1146874B1 (fr)
JP (1)	JP4481504B2 (fr)
KR (1)	KR100620485B1 (fr)
CN (1)	CN1147300C (fr)
AP (1)	AP1534A (fr)
AR (1)	AR035006A1 (fr)
AT (1)	ATE277043T1 (fr)
AU (1)	AU754408B2 (fr)
BG (1)	BG65118B1 (fr)
BR (1)	BR9915879A (fr)
CA (1)	CA2353415A1 (fr)
CO (1)	CO5150166A1 (fr)
CZ (1)	CZ20011963A3 (fr)
DE (1)	DE69920518T2 (fr)
DK (1)	DK1146874T3 (fr)
DZ (1)	DZ2954A1 (fr)
EA (1)	EA003254B1 (fr)
EG (1)	EG24025A (fr)
ES (1)	ES2229798T3 (fr)
HK (1)	HK1042037B (fr)
HU (1)	HUP0104804A3 (fr)
ID (1)	ID28811A (fr)
IL (2)	IL143390A0 (fr)
MA (1)	MA25265A1 (fr)
NO (1)	NO318895B1 (fr)
NZ (1)	NZ511876A (fr)
OA (1)	OA11724A (fr)
PE (1)	PE20001563A1 (fr)
PL (1)	PL195973B1 (fr)
PT (1)	PT1146874E (fr)
SI (1)	SI1146874T1 (fr)
SK (1)	SK7452001A3 (fr)
TR (1)	TR200101654T2 (fr)
TW (1)	TW482673B (fr)
UA (1)	UA71586C2 (fr)
UY (1)	UY25824A1 (fr)
WO (1)	WO2000033838A1 (fr)
ZA (1)	ZA200104398B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UY26780A1 (es) *	2000-06-15	2002-01-31	Pharmacia Corp	Cicloalquil avb3 antagonistas
JP2004513953A (ja) *	2000-10-24	2004-05-13	メルク　エンド　カムパニー　インコーポレーテッド	ジベンズオキサゼピンαＶインテグリン受容体アンタゴニスト
NZ539682A (en)	2001-01-29	2006-03-31	Dimensional Pharm Inc	Substituted indoles and their use as integrin antagonists
US6872730B2 (en)	2001-04-27	2005-03-29	3-Dimensional Pharmaceuticals, Inc.	Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists
US20040224986A1 (en)	2002-08-16	2004-11-11	Bart De Corte	Piperidinyl targeting compounds that selectively bind integrins
EP1572690A1 (fr)	2002-12-20	2005-09-14	Pharmacia Corporation	Composés de thiazole en tant que dérives d'antagonistes des récepteurs de l'integrine
GB0319069D0 (en) *	2003-08-14	2003-09-17	Glaxo Group Ltd	Therapeutically useful compounds
TW200635902A (en) *	2004-12-21	2006-10-16	Smithkline Beecham Corp	Methods and formulations
EP2593452B1 (fr)	2010-07-14	2017-01-18	Novartis AG	Composés hétérocycliques agonistes du récepteur ip
AR089698A1 (es)	2012-01-13	2014-09-10	Novartis Ag	Compuestos heterociclicos antagonistas del receptor ip
ES2637719T3 (es)	2013-02-13	2017-10-16	Novartis Ag	Compuestos heterocíclicos agonistas del receptor IP
PL3050878T3 (pl)	2013-09-24	2022-01-24	Fujifilm Corporation	Zawierający atom azotu związek lub jego sól, lub ich kompleks z metalem

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2687154B1 (fr) *	1992-02-07	1995-05-12	Rhone Poulenc Rorer Sa	Nouveau derive de l'isoindolinone, sa preparation et les compositions pharmaceutiques qui le contiennent.
PT910563E (pt)	1995-06-29	2003-09-30	Smithkline Beecham Corp	Antagonistas de receptores de integrina
WO1998013278A1 (fr) *	1996-09-27	1998-04-02	Merkler, H.	Cuve pour liquides, en particulier pour liquides chimiquement corrosifs
JP2001501951A (ja) *	1996-10-07	2001-02-13	スミスクライン・ビーチャム・コーポレイション	骨形成刺激方法
UY24949A1 (es)	1997-04-08	2001-04-30	Smithkline Beecham Corp	Compuestos calcilíticos

1999
- 1999-03-12 UA UA2001063754A patent/UA71586C2/uk unknown
- 1999-11-29 TW TW088120752A patent/TW482673B/zh not_active IP Right Cessation
- 1999-11-29 UY UY25824A patent/UY25824A1/es unknown
- 1999-11-30 PE PE1999001197A patent/PE20001563A1/es not_active Application Discontinuation
- 1999-11-30 CO CO99075061A patent/CO5150166A1/es unknown
- 1999-12-01 DZ DZ990254A patent/DZ2954A1/fr active
- 1999-12-02 AR ARP990106128A patent/AR035006A1/es unknown
- 1999-12-02 EG EG154299A patent/EG24025A/xx active
- 1999-12-03 EP EP99960647A patent/EP1146874B1/fr not_active Expired - Lifetime
- 1999-12-03 PL PL99348702A patent/PL195973B1/pl not_active IP Right Cessation
- 1999-12-03 PT PT99960647T patent/PT1146874E/pt unknown
- 1999-12-03 KR KR1020017006937A patent/KR100620485B1/ko not_active Expired - Fee Related
- 1999-12-03 WO PCT/US1999/028662 patent/WO2000033838A1/fr not_active Ceased
- 1999-12-03 SI SI9930700T patent/SI1146874T1/xx unknown
- 1999-12-03 DE DE69920518T patent/DE69920518T2/de not_active Expired - Lifetime
- 1999-12-03 US US09/857,316 patent/US6495560B1/en not_active Expired - Lifetime
- 1999-12-03 DK DK99960647T patent/DK1146874T3/da active
- 1999-12-03 TR TR2001/01654T patent/TR200101654T2/xx unknown
- 1999-12-03 AU AU17502/00A patent/AU754408B2/en not_active Ceased
- 1999-12-03 NZ NZ511876A patent/NZ511876A/xx unknown
- 1999-12-03 HU HU0104804A patent/HUP0104804A3/hu unknown
- 1999-12-03 JP JP2000586330A patent/JP4481504B2/ja not_active Expired - Fee Related
- 1999-12-03 ES ES99960647T patent/ES2229798T3/es not_active Expired - Lifetime
- 1999-12-03 CN CNB998159735A patent/CN1147300C/zh not_active Expired - Fee Related
- 1999-12-03 BR BR9915879-5A patent/BR9915879A/pt not_active Application Discontinuation
- 1999-12-03 IL IL14339099A patent/IL143390A0/xx active IP Right Grant
- 1999-12-03 HK HK02101522.3A patent/HK1042037B/en not_active IP Right Cessation
- 1999-12-03 CA CA002353415A patent/CA2353415A1/fr not_active Abandoned
- 1999-12-03 ID IDW00200101183A patent/ID28811A/id unknown
- 1999-12-03 EA EA200100618A patent/EA003254B1/ru not_active IP Right Cessation
- 1999-12-03 SK SK745-2001A patent/SK7452001A3/sk unknown
- 1999-12-03 AP APAP/P/2001/002156A patent/AP1534A/en active
- 1999-12-03 CZ CZ20011963A patent/CZ20011963A3/cs unknown
- 1999-12-03 AT AT99960647T patent/ATE277043T1/de not_active IP Right Cessation
- 1999-12-03 OA OA1200100139A patent/OA11724A/en unknown
2001
- 2001-05-24 IL IL143390A patent/IL143390A/en not_active IP Right Cessation
- 2001-05-29 ZA ZA200104398A patent/ZA200104398B/en unknown
- 2001-06-01 NO NO20012732A patent/NO318895B1/no not_active IP Right Cessation
- 2001-06-01 MA MA26218A patent/MA25265A1/fr unknown
- 2001-06-26 BG BG105651A patent/BG65118B1/bg unknown

Also Published As

Publication number	Publication date
NZ511876A (en)	2004-02-27
EP1146874A4 (fr)	2002-06-05
JP2003523931A (ja)	2003-08-12
HUP0104804A3 (en)	2002-12-28
EA200100618A1 (ru)	2001-12-24
HK1042037B (en)	2005-07-29
CZ20011963A3 (cs)	2001-11-14
ES2229798T3 (es)	2005-04-16
AU1750200A (en)	2000-06-26
BR9915879A (pt)	2002-02-13
CO5150166A1 (es)	2002-04-29
PL195973B1 (pl)	2007-11-30
KR100620485B1 (ko)	2006-09-13
AR035006A1 (es)	2004-04-14
DE69920518D1 (de)	2004-10-28
AP1534A (en)	2006-01-09
TW482673B (en)	2002-04-11
CN1334730A (zh)	2002-02-06
ATE277043T1 (de)	2004-10-15
US6495560B1 (en)	2002-12-17
EG24025A (en)	2008-03-26
ID28811A (id)	2001-07-05
EP1146874A1 (fr)	2001-10-24
BG65118B1 (bg)	2007-03-30
PT1146874E (pt)	2005-02-28
UY25824A1 (es)	2001-07-31
AU754408B2 (en)	2002-11-14
NO318895B1 (no)	2005-05-18
JP4481504B2 (ja)	2010-06-16
NO20012732D0 (no)	2001-06-01
CA2353415A1 (fr)	2000-06-15
PE20001563A1 (es)	2001-02-09
EP1146874B1 (fr)	2004-09-22
EA003254B1 (ru)	2003-02-27
HUP0104804A2 (hu)	2002-05-29
MA25265A1 (fr)	2001-10-01
BG105651A (en)	2002-02-28
IL143390A (en)	2006-07-05
SI1146874T1 (en)	2005-04-30
SK7452001A3 (en)	2001-12-03
NO20012732L (no)	2001-08-01
KR20010080669A (ko)	2001-08-22
WO2000033838A1 (fr)	2000-06-15
ZA200104398B (en)	2002-05-29
DE69920518T2 (de)	2005-09-22
IL143390A0 (en)	2002-04-21
DK1146874T3 (da)	2005-01-31
UA71586C2 (en)	2004-12-15
HK1042037A1 (en)	2002-08-02
TR200101654T2 (tr)	2002-03-21
OA11724A (en)	2005-01-26
PL348702A1 (en)	2002-06-03
CN1147300C (zh)	2004-04-28

Publication	Publication Date	Title
CH689805A8 (fr)	2000-02-29	Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
DZ2773A1 (fr)	2003-12-01	Pyrazolopyrimidinones nouvelles procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2890A1 (fr)	2003-12-15	4-Carboxamino-2-substitué-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA26659A1 (fr)	2004-12-20	Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation.
DZ2866A1 (fr)	2003-12-01	1-Aryl-3-arylméthyl-1,8-naphtyridine-4-(1H)-ones nouvelles, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2963A1 (fr)	2004-03-15	Dérivés de bicycliques substituées nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ3009A1 (fr)	2004-03-27	Dérivés de quinoléine-2-one à substituant hétéroaryle nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2197A1 (fr)	2002-12-02	Dérivés de 6-phénylpyridyl-2-amine, procédé pour leur préparation et compositions pharmaceutiques les contenant.
FR2780057B1 (fr)	2002-09-13	Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26472A1 (fr)	2004-12-20	Derives de n-hydroxy-b-sulfonylpropionamide, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26630A1 (fr)	2004-12-20	4-phenylpyperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
DZ2523A1 (fr)	2003-02-01	Formulations pharmaceutiques contenant du voriconazole et procédé pour leur préparation.
DZ2891A1 (fr)	2003-12-15	Dérivés de tétrahydroquinoléines substués nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA26499A1 (fr)	2004-12-20	Derives de tetrazole, procede pour leur preparation et compositions pharmaceutiques les contenant .
MA26598A1 (fr)	2004-12-20	4-(2-ceto-1-benzimidazolinyl) piperidines nouvelles, procede pour leur préparation et compositions pharmaceutiques les contenant
DZ3042A1 (fr)	2004-03-27	Dérivés d'isothiazole nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2880A1 (fr)	2003-12-15	Dérivés de quinoléine-2-one à substituant alcynylenouveaux procédé pour leur préparation et composi tions pharmaceutiques les contenant.
DZ3045A1 (fr)	2004-03-27	Dérivés de i 3-méthyl-érythromycine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA26514A1 (fr)	2004-12-20	Agonistes de prostaglandines, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26519A1 (fr)	2004-12-20	Derives d'azetidinylpropylpiperidine, procede pour leur preparation et compositions pharmaceutiques les contenant.
DZ2894A1 (fr)	2003-12-15	Compositions pharmaceutiques contenant des dérivésde pyridol Ä1,2-AÜpyrazine et procédé pour leur p réparation.
DZ2155A1 (fr)	2002-10-26	Aazétidines, procédé pour leur préparation, et co mpositions pharmaceutiques les contenant.
DZ2954A1 (fr)	2004-06-20	Antagoniste des recepteurs de vitronectine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
MA26642A1 (fr)	2004-12-20	Derives de sulfonylbenzene nouveaux, procédé pour leur preparation et compositions pharmaceutiques les contenant.
FR2773804B1 (fr)	2000-02-18	Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant